Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 15251-15300 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06700590
First-Line Intervention for PTSD - Intensive Treatment
NARecruiting
186 participants
Started: Nov 21, 2024 · Completed: Jul 1, 2028
1 condition7 sponsors4 locations
NCT06701903
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
PHASE2Recruiting
570 participants
Started: Nov 21, 2024 · Completed: Jun 30, 2027
1 condition1 sponsor15 locations
NCT06678659
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
PHASE1/PHASE2Recruiting
85 participants
Started: Nov 21, 2024 · Completed: Oct 30, 2028
4 conditions1 sponsor6 locations
NCT06682169
Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease
PHASE3Recruiting
182 participants
Started: Nov 20, 2024 · Completed: Dec 31, 2030
1 condition1 sponsor41 locations
NCT06683846
Ivonescimab in the Treatment of Multiple Advanced Tumors
PHASE2Recruiting
400 participants
Started: Nov 20, 2024 · Completed: Nov 30, 2027
19 conditions1 sponsor1 location
NCT06679296
Study on Aging and Cognitive Impairment in China
N/ARecruiting
20,000 participants
Started: Nov 20, 2024 · Completed: Dec 31, 2033
2 conditions2 sponsors1 location
NCT06572241
Quality of Labour Epidural Analgesia With Intrathecal Morphine as a Component of Combined Spinal Epidural
NARecruiting
182 participants
Started: Nov 20, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06511830
Effectiveness of Plaque Score Detection Techniques
N/ARecruiting
50 participants
Started: Nov 20, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06595004
A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients
PHASE3Recruiting
286 participants
Started: Nov 20, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06281028
SOLACEA-H in Heparin-sparing Haemodialysis
NARecruiting
19 participants
Started: Nov 20, 2024 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT06688695
Intervention for Neurodevelopmental Support in Preterm Infants Using Responsive Parenting and E-health
NARecruiting
176 participants
Started: Nov 20, 2024 · Completed: Oct 31, 2029
2 conditions1 sponsor1 location
NCT06349213
Uncovering the Cognitive and Neural Mechanisms Underlying Cognitive Time
N/ARecruiting
130 participants
Started: Nov 20, 2024 · Completed: Nov 1, 2030
1 condition1 sponsor1 location
NCT06718998
A Research Study Comparing Different Ways of Increasing the Dose of NNC0519-0130 in Participants With Overweight or Obesity
PHASE1Recruiting
114 participants
Started: Nov 20, 2024 · Completed: Jan 8, 2026
1 condition1 sponsor1 location
NCT06639854
The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients
NARecruiting
105 participants
Started: Nov 20, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06233448
Thorathic Fluid Content as an Early Predictor of Weaning From Mechanical Ventilation in Acute Respiratory Distress Syndrome
N/ARecruiting
50 participants
Started: Nov 20, 2024 · Completed: Dec 8, 2024
1 condition1 sponsor1 location
NCT06693596
Masses in Young Patients - International Ovarian Tumour Analysis (MY-IOTA)
N/ARecruiting
1,000 participants
Started: Nov 20, 2024 · Completed: Sep 30, 2026
4 conditions1 sponsor1 location
NCT06325371
Italian Multicentric Study on the Treatment of Visceral Aneurysms With the Flow Diversion Stent Derivo Peripher and Derivo 2
N/ARecruiting
100 participants
Started: Nov 20, 2024 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06137664
Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines
PHASE1/PHASE2Recruiting
2,400 participants
Started: Nov 20, 2024 · Completed: Dec 15, 2027
1 condition2 sponsors2 locations
NCT06802250
RINEW Randomized Controlled Trial 7-year Follow-up
NARecruiting
620 participants
Started: Nov 20, 2024 · Completed: Feb 28, 2025
1 condition4 sponsors1 location
NCT06551493
Postnatal Perineal Wound Assessment
N/ARecruiting
20 participants
Started: Nov 20, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT06550219
Evaluation of Nasal Non Invasive Ventilation in Management of Neonates With Respiratory Distress Using Lung Ultrasound
NARecruiting
30 participants
Started: Nov 20, 2024 · Completed: Nov 1, 2025
2 conditions1 sponsor1 location
NCT05856552
The Health and Social Consequences of Depression Among the Elderly
NARecruiting
5,370 participants
Started: Nov 20, 2024 · Completed: Dec 31, 2028
2 conditions2 sponsors2 locations
NCT06683885
A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma
PHASE1/PHASE2Recruiting
80 participants
Started: Nov 20, 2024 · Completed: May 1, 2026
1 condition1 sponsor1 location
NCT06344143
Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma
N/ARecruiting
20 participants
Started: Nov 20, 2024 · Completed: Dec 31, 2030
1 condition2 sponsors1 location
NCT06847113
Maximal and Self-selected Walkingspeed After Knee Arthroplasty - a Prospective Cohort Study
N/ARecruiting
130 participants
Started: Nov 20, 2024 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT06281080
First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours
NARecruiting
10 participants
Started: Nov 20, 2024 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT06506903
Avalus Ultra Post-Approval Study (PAS)
NARecruiting
150 participants
Started: Nov 20, 2024 · Completed: Nov 30, 2026
1 condition1 sponsor13 locations
NCT06789770
Nasal vs Oral Breathing in Drug Induced Sleep vs Natural Sleep
N/ARecruiting
50 participants
Started: Nov 20, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06730308
Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma
PHASE2Recruiting
45 participants
Started: Nov 20, 2024 · Completed: Nov 19, 2028
1 condition1 sponsor1 location
NCT06816797
Testing the Cog-Fun Aging Program for Older Adults With Subjective Cognitive Decline
NARecruiting
40 participants
Started: Nov 20, 2024 · Completed: Aug 31, 2025
3 conditions2 sponsors3 locations
NCT06690775
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
PHASE2Recruiting
230 participants
Started: Nov 20, 2024 · Completed: Dec 31, 2027
4 conditions2 sponsors42 locations
NCT07022977
A Study of MET233 in Individuals With Obesity or Overweight
PHASE1/PHASE2Recruiting
120 participants
Started: Nov 20, 2024 · Completed: Jan 3, 2026
1 condition1 sponsor1 location
NCT06065371
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
PHASE1Recruiting
20 participants
Started: Nov 20, 2024 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT06659042
Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer
PHASE2Recruiting
32 participants
Started: Nov 20, 2024 · Completed: Nov 20, 2027
1 condition1 sponsor1 location
NCT06305117
Virtual RealiTy and mUsic in the Oncology SEtting - Phase 1
NARecruiting
60 participants
Started: Nov 20, 2024 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT06631092
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer
PHASE1/PHASE2Recruiting
8 participants
Started: Nov 20, 2024 · Completed: Dec 31, 2028
1 condition2 sponsors2 locations
NCT06955611
Is Community Based Monitoring of Diabetic Maculopathy and Pre-proliferative Diabetic Retinopathy Safe?
NARecruiting
150 participants
Started: Nov 20, 2024 · Completed: Sep 30, 2025
3 conditions2 sponsors1 location
NCT06686355
The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula
PHASE2Recruiting
80 participants
Started: Nov 20, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06695013
Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL
PHASE2Recruiting
144 participants
Started: Nov 20, 2024 · Completed: Mar 20, 2027
2 conditions1 sponsor1 location
NCT06739109
Guided Internet-Based Treatment for Harmful Alcohol Use; EBehandling Alkohol
NARecruiting
250 participants
Started: Nov 20, 2024 · Completed: Dec 31, 2029
1 condition5 sponsors5 locations
NCT06686927
Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP
PHASE2Recruiting
36 participants
Started: Nov 20, 2024 · Completed: Dec 20, 2025
1 condition4 sponsors1 location
NCT06714708
Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC
PHASE2Recruiting
86 participants
Started: Nov 20, 2024 · Completed: Jun 1, 2027
4 conditions1 sponsor1 location
NCT06881043
The Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer
N/ARecruiting
300 participants
Started: Nov 20, 2024 · Completed: Dec 1, 2029
2 conditions5 sponsors1 location
NCT06888063
Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery
PHASE2Recruiting
40 participants
Started: Nov 20, 2024 · Completed: Sep 30, 2031
4 conditions2 sponsors1 location
NCT05923632
The Effect Of Model-Based Dıgıtal Game On Metabolıc Control, Self-Effıcıency And Qualıty Of Lıfe In Chıldren Wıth Type 1 Dıabetes
NARecruiting
58 participants
Started: Nov 20, 2024 · Completed: Dec 30, 2025
2 conditions1 sponsor2 locations
NCT06794307
Blood Glucose in Pregnant Non-diabetic Women During Treatment With Betamethasone for Fetal Lung Maturation
N/ARecruiting
25 participants
Started: Nov 20, 2024 · Completed: Jan 31, 2026
4 conditions1 sponsor1 location
NCT06734637
Efficacy and Safety of Peginterferon in ET and PV.
NARecruiting
40 participants
Started: Nov 20, 2024 · Completed: Nov 20, 2027
2 conditions1 sponsor1 location
NCT06697106
Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?
NARecruiting
82 participants
Started: Nov 20, 2024 · Completed: Apr 1, 2025
4 conditions1 sponsor1 location
NCT06515301
Key Interventions to Improve the Follow-up Adherence Post Cervical Precancerous Lesion Treatment in Ethiopia
NARecruiting
466 participants
Started: Nov 20, 2024 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT07115238
Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD
PHASE3Recruiting
354 participants
Started: Nov 20, 2024 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location